Aug 2026
Myeloperoxidase/ASGPR Dual-Targeting Self-Amplifying Nanoplatform for Synergistic Anti-Metastatic Therapy of Hepatocellular Carcinoma.
A dual-targeted nanotherapeutic platform (SC@GRT-COF-366) based on a covalent organic framework (COF-366) is reported for synergistic HCC treatment, offering a promising strategy for advanced HCC treatment.
Le Wang, Xiang Wang, Hengrui Li et al.
· Small · 0 citations